1. Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6
    YONG WEON YI et al, 2015 CrossRef
  2. Propofol induces proliferation partially via downregulation of p53 protein and promotes migration via activation of the Nrf2 pathway in human breast cancer cell line MDA-MB-231
    Chao Meng et al, 2017 CrossRef
  3. iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding
    Wenjie Ge et al, 2017, Cancer Cell CrossRef
  4. ROS Modulator Molecules with Therapeutic Potential in Cancers Treatments.
    Carole Nicco et al, 2017, Molecules CrossRef
  5. Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells.
    Hong-Quan Duong et al, 2017, Antioxidants (Basel) CrossRef
  6. Antiinflammatory and antioxidant effects of gemcitabinein collagen-induced arthritis model
    Adile Ferda DAĞLI et al, 2017, Turk J Med Sci CrossRef
  7. Identification of Hsp90 Inhibitors with Anti-Plasmodium Activity
    Dora Posfai et al, 2018, Antimicrob Agents Chemother CrossRef
  8. Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway
    Yukai Xiang et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
  9. Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication
    Olivia Perwitasari et al, 2015, ASSAY and Drug Development Technologies CrossRef
  10. Cellular and molecular responses to acute cocaine treatment in neuronal-like N2a cells: potential mechanism for its resistance in cell death
    Ramesh B. Badisa et al, 2019, Cell Death Discovery CrossRef
  11. Potential Applications of NRF2 Inhibitors in Cancer Therapy
    Emiliano Panieri et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  12. HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction
    Hyo Jin Kang et al, 2015, Sci Rep CrossRef
  13. Comparative analysis of NRF2-responsive gene expression in AcPC-1 pancreatic cancer cell line
    Yong Weon Yi et al, 2015, Genes Genom CrossRef
  14. Keap1–Nrf2 signalling in pancreatic cancer
    Alastair J. Hayes et al, 2015, The International Journal of Biochemistry & Cell Biology CrossRef
  15. The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells
    Sarah Arfmann-Knübel et al, 2015, PLoS ONE CrossRef
  16. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
    Xupeng Bai et al, 2016, Drug Metabolism Reviews CrossRef
  17. Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review.
    Jiang-Jiang Qin et al, 2019, Cell Commun Signal CrossRef
  18. null
    Jose J.G. Marin et al, 2020 CrossRef
  19. NRF2 in regulating cancer metabolism
    Katarína Smolková et al, 2020, Antioxidants & Redox Signaling CrossRef
  20. BMP8A promotes survival and drug resistance via Nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma
    Yi‐peng Yu et al, 2020, Cancer Sci CrossRef
  21. Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer
    Fengjin Zhao et al, 2015, Oncotarget CrossRef
  22. Isoform-Selective PI3K Inhibitors for Various Diseases
    Rammohan R.Y. Bheemanaboina, 2020, CTMC CrossRef
  23. Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis.
    Qiqing Sun et al, 2020, Oncogene CrossRef
  24. Molecular Therapeutics of Pancreatic Ductal Adenocarcinoma: Targeted Pathways and the Role of Cancer Stem Cells
    Andrei-Florian Stoica et al, 2020, Trends in Pharmacological Sciences CrossRef
  25. Kaempferol inhibits Nrf2 signalling pathway via downregulation of Nrf2 mRNA and induces apoptosis in NSCLC cells
    Chandrani Fouzder et al, 2020, Archives of Biochemistry and Biophysics CrossRef
  26. Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation.
    Huai-Qiang Ju et al, 2015, Mol Cancer Ther CrossRef
  27. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.
    Aaron T Scott et al, 2020, Clin Cancer Res CrossRef
  28. INHIBITION OF THE NRF2/KEAP1 AXIS: A PROMISING THERAPEUTIC STRATEGY TO ALTER REDOX BALANCE OF CANCER CELLS
    Emiliano Panieri et al, 2021, Antioxidants & Redox Signaling CrossRef
  29. Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
    Pelin Telkoparan-Akillilar et al, 2021, Molecules CrossRef
  30. Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells
    Kyu Sic You et al, 2021, Cancers CrossRef
  31. Organismal roles for the PI3Kα and β isoforms: their specificity, redundancy or cooperation is context-dependent
    Silvia Arcucci et al, 2021 CrossRef
  32. Mechanisms of Cancer Cell Death: Therapeutic Implications for Pancreatic Ductal Adenocarcinoma
    Hannah Pook et al, 2021, Cancers CrossRef
  33. Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer
    Jianhui Yang et al, 2021, IJMS CrossRef
  34. Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?
    Yong Weon Yi et al, 2021, IJMS CrossRef
  35. Role of Nrf2 in Pancreatic Cancer
    Marta Cykowiak et al, 2021, Antioxidants CrossRef
  36. Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma
    L. K. Kadian et al, 2022, Clin Transl Oncol CrossRef
  37. Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response
    Koraljka Gall Trošelj et al, 2022, Molecules CrossRef
  38. null
    Kannappan Sriramajayam et al, 2022 CrossRef
  39. Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway
    Juan Zhang et al, 2022, J Exp Clin Cancer Res CrossRef
  40. null
    Kannappan Sriramajayam et al, 2022 CrossRef
  41. The RSL3 Induction of KLK Lung Adenocarcinoma Cell Ferroptosis by Inhibition of USP11 Activity and the NRF2-GSH Axis
    Wenlong Zhang et al, 2022, Cancers CrossRef
  42. Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway
    Bingbing Dai et al, 2021, Cell Death Dis CrossRef
  43. Brusatol: A potential sensitizing agent for cancer therapy from Brucea javanica
    Ting He et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  44. NFR2/ABC transporter axis in drug resistance of breast cancer cells
    Zinat Sargazi et al, 2023, Mol Biol Rep CrossRef
  45. PIK Your Poison: The Effects of Combining PI3K and CDK Inhibitors against Metastatic Cutaneous Squamous Cell Carcinoma In Vitro
    Jay R. Perry et al, 2024, Cancers CrossRef
  46. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
    Ming Gu et al, 2024, Cancer Letters CrossRef
  47. The Role of Nrf2 in the Regulation of Mitochondrial Function and Ferroptosis in Pancreatic Cancer
    Dinara Baiskhanova et al, 2024, Antioxidants CrossRef